Genesee Valley Trust’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-6,520
Closed -$1.39M 312
2014
Q4
$1.39M Sell
6,520
-6,660
-51% -$1.32M 0.89% 25
2014
Q3
$2.35M Buy
13,180
+303
+2% +$50.3K 1.46% 7
2014
Q2
$2.18M Sell
12,877
-146
-1% -$22.7K 1.31% 9
2014
Q1
$1.62M Buy
13,023
+3,791
+41% +$462K 1.02% 13
2013
Q4
$1.02M Buy
9,232
+2,183
+31% +$209K 0.68% 29
2013
Q3
$638K Buy
7,049
+522
+8% +$46.9K 0.47% 53
2013
Q2
$550K Buy
+6,527
New +$677K 0.43% 57

Other funds holding AGN

Genesee Valley Trust's AGN Position: Q1 2015 in Review

Genesee Valley Trust sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 6,520 shares — an estimated $1.39M sold.

Genesee Valley Trust first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $2.35M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Genesee Valley Trust reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Genesee Valley Trust sold 6,520 Allergan Inc shares in Q1 2015, an estimated $1.39M.
  • Genesee Valley Trust first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Genesee Valley Trust's Allergan Inc position peaked at $2.35M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Genesee Valley Trust's 13F filing for Q1 2015, filed 7 May 2015.